Christopher Brian Locke

Bournemouth, United Kingdom

Christopher Brian Locke

This inventor holds 540 USPTO granted patents and 212 published patent applications, plus 77 CIPO patents and 314 EPO patents, primarily in Negative Pressure Therapy (CPC class A61M1-0088). Top assignees: Kci Licensing, Inc., Solventum Intellectual Properties Company, 3M Innovative Properties Company. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Brian Locke. Retrieved from https://idiyas.com/inventor/christopher-brian-locke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 540 

% Patents Active = 91.3

 

 

Average Co-Inventor Count = 2.5

ph-index = 44

Forward Citations = 6,246(Granted Patents)

Forward Citations (Not Self Cited) = 5,279(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Muscliffe, GB (2012)
  • Boumemouth, GB (2009 - 2015)
  • Bournermouth, GB (2017)
  • Bornemouth, GB (2017 - 2018)
  • Dorset, GB (2017 - 2018)
  • Bournemoth, GB (2018)
  • Bournemouth, GB (2008 - 2024)
  • Blandford Forum, GB (2023 - 2024)

Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Negative Pressure
Wound Dressing
Fluid Management
Sensor Integration
Moisture Measurement
Adhesive Technology
Therapy Systems
Dressing Design
Pump Control
Fluid Instillation
Tissue Treatment
Remote Monitoring
540 patents (USPTO):Explore Patents

Title: Christopher Brian Locke: Innovator in Medical Technology

Introduction

Christopher Brian Locke is a renowned inventor based in Bournemouth, GB. With an impressive portfolio of 497 patents, he has made significant contributions to the field of medical technology. His inventions display a deep understanding of complex biomedical challenges and innovative solutions.

Latest Patents

Among Locke's latest patents is a **manifolding apparatus or dressing exhibiting low tissue ingrowth and negative-pressure treatment method**. This apparatus is designed for wound care, featuring an array of interconnected truncated ellipsoids that define fluid pathways. The design ensures each ellipsoid's principal axis is perpendicular to the array, enhancing fluid movement. The dressing includes a coupling to the apparatus, a backing layer, and an attachment device, all optimized for negative-pressure therapy on various tissue sites. Another notable patent is a **medical system and dressing for use under compression**, which details a bridge suitable for treating tissue sites, equipped with a sealing member and wicking layers that facilitate effective treatment.

Career Highlights

Christopher Brian Locke has been instrumental in advancing medical technologies through his roles in several companies, including KCI Licensing, Inc. and Solventum Intellectual Properties Company. His work has focused on improving therapeutic devices and systems that enhance patient care and recovery.

Collaborations

In his career, Locke has collaborated with notable professionals, including Timothy Mark Robinson and Aidan Marcus Tout. These collaborations have likely contributed to the innovative spirit and quality of his inventions, enabling breakthroughs in medical treatments.

Conclusion

Christopher Brian Locke's extensive patent portfolio and dedication to his craft position him as a leading inventor in medical technology. His innovative approaches to wound care and negative-pressure therapies reflect a strong commitment to improving patient outcomes through advanced inventions. As he continues to push the boundaries of what's possible in medical treatments, his contributions will undoubtedly leave a lasting impact on the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…